2023年1月30日

下午3:36 Docquity報道,它幫助菲律賓的製藥公司在疼痛治療的治療領域獲得10%的市場份額在短短一年通過其專有Docquity意識宣傳(負責)計劃。該公司表示利用Docquity HCP廣闊的網絡,HCP需求的深刻理解和偏好和健壯omnichannel解決方案,這種方法補充客戶的銷售和營銷團隊改善HCP達到2.5 x通過近30000接觸點,並提高轉化率和收入,在成本的17%部署等傳統方法麵對麵的醫療代表。Docquity車載客戶端負責計劃,從理解客戶的當前品牌認知通過其網絡和部署目標學校,omnichannel拓展提高意識。客戶製造疼痛產品具有不同的作用機製,提供一個綜合疼痛管理方法,可以更有效的對某些病人。然而,疼痛產品市場因promotion-sensitive,混合的處方藥和非處方藥(OTC)的競爭對手。當客戶需要提高認識和教育醫生在其產品的作用和好處的疼痛管理方法,其醫療代表最初與隻有大約15%的學校治療病人的疼痛和市場相關的症狀。解決這些挑戰,Docquity車載客戶端負責計劃,從理解客戶的當前品牌認知通過其網絡和部署目標學校,omnichannel推廣以提高品牌的關鍵信息的認識和建立信任通過科學教育。Docquity然後不斷地測量了在營銷組的學校之旅,從意識隊列(學校與關鍵信息在Docquity和社會媒體渠道)信托隊列(學校進一步與科學教育內容,如案例研究和課程,Docquity平台)和倡導隊列(學校表示有興趣客戶端的調用操作(CTA))。基於這種方法,Docquity杠杆其虛擬醫學代表(VMRs)集中與學校的對話,支持通過Docquity HCP偏好產生的見解的平台。“通過Docquity專有的,負責的方法,我們的客戶在菲律賓能夠建立一個更有針對性的學校誰能識別特定的情況下,其產品是高度相關的。 This enabled the client to cultivate meaningful relationships with the right HCPs through the right messages and channels, overcome industry competition and achieve remarkable business results,” Amit Vithal, co-founder and chief growth officer at Docquity, said. “Our network and expertise as a trusted digital platform connecting and enabling HCPs in Southeast Asia puts us in a unique position to continue developing this approach to support healthcare organizations looking to improve engagements with doctors.” With solid results delivered in just 12 months, Docquity and the client have since progressed towards a long-term, commercial partnership model, where Docquity is equally aligned with the client’s business goals and brand’s growth. Docquity is in further discussions with more healthcare organizations across Southeast Asia to demonstrate the value of its A2A program and embark on a shared journey to empower HCPs to build healthier lives at scale. Facebook Comments Box